Cardiopulmonary

A Patient Registry of the Real-world Use of Oral Treprostinil

For more information visit: ClinicalTrials.gov

A 16-Week, Multicenter, Open-label Study of Parenteral Treprostinil Induction Followed by Oral Treprostinil Optimization in Subjects With Pulmonary Arterial Hypertension

For more information visit: ClinicalTrials.gov

A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects With Pulmonary Hypertension Due to Parenchymal Lung Disease

For more information visit: ClinicalTrials.gov

A Phase 3, Randomized, Placebo-controlled, Double-blind, Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Patients With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease

For more information visit: ClinicalTrials.gov

A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects With Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction

For more information visit: ClinicalTrials.gov

Oncology

A Two-part, Open-label, Randomized, Phase 2/3 Study of Dinutuximab and Irinotecan Versus Irinotecan for Second Line Treatment of Subjects With Relapsed or Refractory Small Cell Lung Cancer

For more information visit: ClinicalTrials.gov